期刊文献+

鞘内注射单羧酸转运蛋白抑制剂α-氰基-4-羟基肉桂酸缓解大鼠神经病理性疼痛 被引量:1

Intrathecal injection of monocarboxylate transporter inhibitor α-cyano-4-hydroxy-cinnamate attenuates neuropathic pain in rats
原文传递
导出
摘要 目的 观察鞘内注射4-CIN对坐骨神经慢性缩窄性损伤(CCI)大鼠神经病理性疼痛的影响.方法 18只雄性SD大鼠按随机数字表法分为3组(n=6):假手术组(S组)、CCI组(C0组)及4-CIN组(C1组).C0组与C1组建立CCI动物模型,S组仅分离而不结扎坐骨神经.术后第2天,C1组鞘内注射溶解于10%二甲基亚砜(DMSO) 10μl中的4-CIN(α-cyano-4-hydroxy-cinnamate)100 μmol,C0组仅鞘内注射DMSO10μl.各组在术前1d、术后第1,3,7,10,14天(T0-5)测定大鼠机械缩足反应阈值(PWMT)和热缩足反应潜伏期(PWTL).结果 各组术前PWMT和PWTL差异无统计学意义(P>0.05).与S组相比,C0组在T1-5时PWMT[(11.71±2.81)g,(9.76±1.00)g,(8.22±1.33)g,(6.50± 1.48)g,(4.67± 1.03)g]、PWTL[(11.36±2.18)s,(11.60±2.54)s,(8.54±1.42)s,(7.59±1.00)s,(6.88±0.42)s]均出现明显降低(P<0.05),而C1组在给药后T2-5时与S组无明显差异(P>0.05).结论 鞘内注射4-CIN可缓解CCI所致的慢性神经病理性疼痛. Objective To investigate the effects of intrathecal injection of α-cyano-4-hydroxy-cinnamate (4-CIN) in rats with neuropathic pain induced by chronic constriction injury of sciatic nerve (CCI).Methods Eighteen male SD rats were divided randomly into 3 groups(n=6):sham group (group S),CCI model group (group C0) and 4-CIN group (group C1).Group C0 and C1 were operated with the model of neuropathic pain induced by chronic constriction injury of sciatic nerve ; and group S were treated as sham operated rats.Two days after operation,group C1 received intrathecal injection of 100 μmol 4-CIN dissolved in 10% DMSO 10 μl,while group C0 received intrathecal injection of 10% DMSO 10 μl only.The paw withdrawal thermal latency(PWTL) and paw withdrawal mechanical threshold(PWMT) were tested 1 d before operation and 1 d,3 d,7 d,10 d,14 d after operation(T0-5).Results The basic values of PWMT and PWTL before operation showed no statistically significant differences among the three groups.On T1-5,the PWMT((11.71 ±2.81) g,(9.76± 1.00) g,(8.22± 1.33) g,(6.50± 1.48) g,(4.67± 1.03) g) and PWTL((11.36±2.18) s,(11.60±2.54) s,(8.54± 1.42) s,(7.59± 1.00) s,(6.88± 0.42) s) in group C0 were significantly lower than those in group S (P〈0.05).However,there were no significant differences between group S and C1 on T2-5(P〉0.05).Conclusion Intrathecal administration of 4-CIN can attenuate neuropathic pain in rats induced by CCI.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2014年第10期869-871,共3页 Chinese Journal of Behavioral Medicine and Brain Science
基金 国家自然科学基金项目(81070892,81171048,81171047,81300950) 江苏省医学重点学科(XK201140)
关键词 单羧酸转运蛋白 抑制剂4-CIN 神经病理性疼痛 脊髓 抑制剂4-CIN Monocarboxylate transporter Inhibitor 4-CIN Neuropathic pain Spinal cord
  • 相关文献

参考文献13

  • 1Ruscheweyh R,Wilder-Smith O,Drdla R,et al.Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy[J].Mol Pain,2011,7(1):20.
  • 2Bennett GJ,Xie YK.A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man[J].Pain,1988,33(1):87-107.
  • 3Hylden JL,Wilcox GL.Intrathecal morphine in mice:a new technique[J].Eur J Pharmacol,1980,67(2):313-316.
  • 4Chaplan SR,Bach FW,Pogrel JW,et al.Quantitative assessment of tactile allodynia in the rat paw[J].J Neurosci Methods,1994,53(1):55-63.
  • 5Hargreaves K,Dubner R,Brown F,et al.A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia[J].Pain,1988,32(1):77-88.
  • 6Adolph O,Fohr KJ.Targeting spinal long-term potentiation as a basis for anlagesia-recent developments[J].Curr Clin Pharmacol,2012,7(1):1-6.
  • 7Drdla-Schutting R,Benrath J,Wunderbaldinger G,et al.Erasure of a spinal memory trace of pain by a brief,high-dose opioid administration[J].Science,2012,335(6065):235-238.
  • 8程丽,景玮,王改弟,郭亮,祁金顺.淀粉样β蛋白对大鼠在体海马长时程压抑的增强效应[J].中华行为医学与脑科学杂志,2012,21(12):1060-1063. 被引量:5
  • 9韩维娜,原丽,刘晓杰,周丽薇,武美娜,祁金顺.大鼠空间学习记忆和海马长时程增强的相关性研究[J].中华行为医学与脑科学杂志,2012,21(7):630-633. 被引量:13
  • 10Suzuki A,Stern SA,Bozdagi O,et al.Astrocyte-neuron lactate transport is required for long-term memory formation[J].Cell,2011,144(5):810-823.

二级参考文献21

  • 1Selkoe DJ. The cell biology of bela-amyloid precursor protein and pre- senilin in Alzheimer~ disease. Trends Cell Biol, 1998,8:447-453.
  • 2Chen QS, Kagan BL, Hirakura Y, et al. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res, 2000,60 : 65 -72.
  • 3Zetterberg H, Blennow K, Hanse E. Amyloid beta and APP as biomar- kers for Alzheimersdisease. Exp Gerontol,2010 ,45 :23-29.
  • 4Stepanichev MY, Moiseeva YV, Lazareva NA, et al. Studies of the effects of fragment ( 25-35 ) of beta-amyloid peptide on the behavior of rats in a radial maze. Neurosci Behav Physiol,2005 ,35 :511-518.
  • 5Pan YF, Chen XR, Wu MN, et al. Arginine vasopressin prevents a- gainst Abeta (25-35)-induced ipairment of spatial learning and memory in rats. Horm Behav,2010,57:448-454.
  • 6Sakono M,Zako T, Maeda M. Naked-eye detection of amyloid aggre- gates using gold nanoparticles modified with amyloid beta antibody. Anal Sei,2012,28:73.
  • 7Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods,1984,11:47-60.
  • 8Korte M,Herrmann U,Zhang X,ct al. The role of APP and APLP for synaptic transmission, plasticity, and network function : lessons from genetic mouse models. Exp Brain Res,2011,217 :435-440.
  • 9Alkam T, Nitta A, Mizoguchi H, et al. A natural scavenger of per- oxynitrites, rosmarinic acid, protects against impairment of memory in- duced by Abeta ( 25-35 ). Behav Brain Res,2007,180 : 139-145.
  • 10hoh A, Akaike T, Sokabe M, et al. Impairments of long-term potentia- tion in hippocampal slices of beta-amyloid-infused rats. Eur J Pharma- col, 1999,382 : 167-175.

共引文献15

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部